Oxcarbazepine
Oxcarbazepine is an antiseizure medicine used to treat partial-onset seizures in adults and children, available as tablets, extended-release tablets, and oral suspension.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 77 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Oxcarbazepine: Patient Information Guide
A plain-language walkthrough of Oxcarbazepine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Oxcarbazepine is an antiseizure medicine approved to treat partial-onset seizures — seizures that begin in a specific area of the brain.
- Oxcarbazepine tablets are approved for adults as monotherapy (used alone) or adjunctive therapy (added to other seizure medicines) for partial-onset seizures.
- Oxcarbazepine tablets are approved for children aged 4–16 as monotherapy and for children aged 2–16 as adjunctive therapy for partial-onset seizures.
- Trileptal (tablets and oral suspension) is approved for adults with partial-onset seizures as monotherapy or adjunctive therapy, and for children aged 4–16 as monotherapy and aged 2–16 as adjunctive therapy.
- Oxcarbazepine oral suspension is approved for adults as monotherapy or adjunctive therapy, and for children aged 4–16 as monotherapy and aged 2–16 as adjunctive therapy for partial-onset seizures.
- Oxcarbazepine extended-release tablets are approved for partial-onset seizures in patients 6 years of age and older.
- Oxtellar XR (tablet) is approved for partial-onset seizures in patients 6 years of age and older.
⚙️How it works▾
Oxcarbazepine is rapidly converted in the body to an active compound called MHD (10-monohydroxy metabolite), which does most of the work. MHD blocks voltage-sensitive sodium channels — the electrical switches that nerve cells use to fire. By blocking these channels, it calms overactive nerve cells, stops them from firing repeatedly, and prevents a seizure from spreading through the brain. Additional effects on potassium and calcium channels may also contribute to its antiseizure action.
💊How it's taken▾
Oxcarbazepine comes in tablets, oral suspension, and extended-release tablets — all taken by mouth. Tablets and oral suspension are typically taken twice daily; the extended-release tablet is taken once daily. Tablets and oral suspension can be taken with or without food.
- Do not stop taking oxcarbazepine suddenly — your doctor will reduce the dose gradually to avoid triggering dangerous seizures.
- If your kidneys are not working well, your doctor will adjust your dose accordingly.
- Follow your prescriber's instructions exactly; do not adjust the dose on your own.
🤒Side effects — in detail▾
The most common side effects of oxcarbazepine include:
- Dizziness
- Drowsiness or fatigue
- Double vision (diplopia) or blurred vision
- Nausea or vomiting
- Headache
- Unsteady walking or poor coordination (ataxia)
- Involuntary eye movements (nystagmus)
- Tremor
Serious reactions — including severe skin rashes, dangerous drops in blood sodium, signs of suicidal thoughts, or allergic reactions involving throat swelling — require immediate medical attention. Contact your doctor or go to the emergency room right away if these occur.
⚠️Warnings & precautions▾
- Low sodium (hyponatremia): Oxcarbazepine can cause sodium levels to drop to dangerous lows, especially in the first 3 months. Watch for nausea, headache, confusion, or worsening seizures, and tell your doctor immediately.
- Serious skin reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis — rare but potentially life-threatening rashes — have been reported. Stop taking oxcarbazepine and seek care right away if you develop a severe or spreading rash, blistering, or skin peeling. People who carry the HLA-B*1502 gene variant (more common in some Asian populations) may be at higher risk.
- Suicidal thoughts and behavior: All antiseizure medicines, including oxcarbazepine, slightly increase the risk of suicidal thinking. Notify your doctor right away about any new or worsening depression, mood changes, or thoughts of self-harm.
- Severe allergic reactions (anaphylaxis/angioedema): Swelling of the face, throat, or tongue can be life-threatening. Seek emergency help immediately.
- Do not stop suddenly: Abruptly stopping oxcarbazepine can cause prolonged dangerous seizures (status epilepticus). Always taper with your doctor's guidance.
- Driving and machinery: Oxcarbazepine can impair coordination, concentration, and alertness — do not drive until you know how it affects you.
🔀What it interacts with▾
Oxcarbazepine can interact with several medications — always tell your prescriber and pharmacist everything you take.
- Phenytoin: Oxcarbazepine can raise phenytoin blood levels, increasing the risk of phenytoin toxicity. Your doctor may need to lower the phenytoin dose.
- Carbamazepine, phenytoin, phenobarbital, and rifampin: These drugs lower the level of oxcarbazepine's active form (MHD) in your blood by 25–49%, which could make oxcarbazepine less effective. Dose adjustments may be needed.
- Hormonal contraceptives (birth control pills or implants): Oxcarbazepine reduces the effectiveness of contraceptives containing ethinylestradiol or levonorgestrel. Use an additional non-hormonal method of birth control.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not take oxcarbazepine if you have had an allergic reaction to oxcarbazepine, any of its ingredients, or eslicarbazepine acetate.
- Tell your doctor if you have ever had an allergic reaction to carbamazepine — about 25–30% of those patients will also react to oxcarbazepine.
- Tell your doctor if you have kidney problems; a dose reduction is needed if your kidneys are not functioning well.
- People of Han Chinese, Thai, Filipino, Malaysian, Korean, or Indian ancestry should discuss genetic testing (HLA-B*1502) with their doctor before starting, due to a higher risk of serious skin reactions.
- Tell your doctor if you are pregnant or trying to become pregnant. Animal studies showed fetal harm; do not stop oxcarbazepine without talking to your doctor, as uncontrolled seizures during pregnancy carry serious risks.
- Oxcarbazepine and its active metabolite pass into breast milk. Discuss risks and benefits with your doctor.
- Women of childbearing age using hormonal birth control should use additional or alternative non-hormonal contraception while taking oxcarbazepine.
- Older adults build up higher blood levels of the drug due to reduced kidney function — closer monitoring, especially of sodium levels, is needed.
🚑If you take too much▾
Taking too much oxcarbazepine can cause nausea, vomiting, drowsiness, dizziness, tremor, low blood pressure, confusion, and in severe cases, coma or seizures. There is no specific antidote. If you suspect an overdose, call Poison Control (1-800-222-1222) or go to an emergency room immediately — treatment is supportive and focused on managing symptoms.
📡Pharmacodynamics — effects in the body▾
Oxcarbazepine and its active metabolite MHD have antiseizure effects demonstrated in animal models — protecting against electrically and chemically triggered seizures and reducing recurring focal seizures. Importantly, studies in animals showed no development of tolerance (meaning the medicine did not become less effective over time with repeated daily use).
🔬Pharmacokinetics — how your body processes it▾
After you take oxcarbazepine by mouth, it is almost completely absorbed and quickly converted by the liver into its active form, MHD, which is responsible for the antiseizure effect. The original oxcarbazepine molecule has a short half-life of about 2 hours, while MHD stays in the body longer with a half-life of about 9 hours. MHD is then processed further and eliminated mainly through the kidneys — over 95% of the drug leaves the body in the urine. In older adults and in young children (who clear MHD faster per pound of body weight), blood levels may differ significantly from those in other adults, so prescribers adjust doses accordingly.
📦How to store it▾
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F) . Dispense in tight container (USP). Store TRILEPTAL oral suspension in the original container.
📄 Written from Oxcarbazepine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Oxcarbazepine
122 supplements and herbal products have documented interactions with Oxcarbazepine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 7
- Moderate · 99
- Minor · 16
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Oxcarbazepine has been associated with lower levels of 2 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 1
- Moderate · 1
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Oxcarbazepine — the kind of thing our pharmacy team would talk through with you at the counter.
What is oxcarbazepine actually used for? ▾
How should I take it — does it matter if I take it with food? ▾
What side effects should I actually expect, and which ones mean I should call my doctor? ▾
Can I just stop taking it if I feel better or if the side effects bother me? ▾
Does this medication affect my birth control? ▾
Is it safe to take during pregnancy? ▾
Is Oxcarbazepine available over the counter? ▾
When was Oxcarbazepine first available? ▾
Who makes Oxcarbazepine? ▾
💬 Answers drafted from Oxcarbazepine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Oxcarbazepine comes
Oxcarbazepine is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Oxcarbazepine tablets are approved for partial-onset seizures in adults as monotherapy or adjunctive therapy.
- Oxcarbazepine tablets are approved for partial-onset seizures in children aged 4–16 as monotherapy and in children aged 2–16 as adjunctive therapy.
- Trileptal tablets are approved for partial-onset seizures in adults as monotherapy or adjunctive therapy, and in children aged 4–16 as monotherapy and aged 2–16 as adjunctive therapy.
- Oxcarbazepine tablets and Trileptal tablets can be taken with or without food.
- Oxcarbazepine tablets are typically taken twice a day — follow your prescriber's specific schedule.
- Do not stop Trileptal or oxcarbazepine tablets abruptly; the dose should be reduced gradually under your doctor's guidance.
Oral suspension
How this form is used
- Trileptal oral suspension is approved for partial-onset seizures in adults as monotherapy or adjunctive therapy.
- Trileptal oral suspension is approved for partial-onset seizures in children aged 4–16 as monotherapy and in children aged 2–16 as adjunctive therapy.
- Oxcarbazepine oral suspension is approved for partial-onset seizures in adults as monotherapy or adjunctive therapy, and in children aged 4–16 as monotherapy and aged 2–16 as adjunctive therapy.
- Trileptal and oxcarbazepine oral suspension can be taken with or without food.
- Oxcarbazepine oral suspension is typically taken twice a day — follow your prescriber's specific schedule.
- Shake the oral suspension well before each use and measure doses carefully with the provided measuring device.
Extended-release tablet
How this form is used
- Oxcarbazepine extended-release tablets are approved for partial-onset seizures in patients 6 years of age and older.
- Oxcarbazepine extended-release tablets are taken once daily by mouth.
- Follow your prescriber's instructions for Oxcarbazepine extended-release tablets and do not stop taking them suddenly.
📊 Oxcarbazepine across the U.S. market
How Oxcarbazepine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (29) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Oxcarbazepine is used
A general measure of how commonly Oxcarbazepine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Oxcarbazepine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Oxcarbazepine prescribed? Of the 1,596 medications we measure, Oxcarbazepine ranks #127 by Medicaid prescriptions — more than 92% of them.
Utilization by Oxcarbazepine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
oxcarbazepine 300 MG Oral Tablet Most dispensed
Summed across the 21 of 98 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 312137
oxcarbazepine 150 MG Oral Tablet
Summed across the 13 of 73 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 312136
oxcarbazepine 600 MG Oral Tablet
Summed across the 15 of 75 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 312138
oxcarbazepine 60 MG/ML Oral Suspension
Summed across the 9 of 36 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 283536
24 HR oxcarbazepine 600 MG Extended Release Oral Tablet
Summed across the 4 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1365844
24 HR oxcarbazepine 300 MG Extended Release Oral Tablet
Summed across the 4 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1365842
24 HR oxcarbazepine 150 MG Extended Release Oral Tablet
Summed across the 4 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1365653
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Oxcarbazepine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 70 of 306 listed Oxcarbazepine NDCs with Medicaid activity.
🔍 Compare Oxcarbazepine products
A representative set of FDA-listed product records for Oxcarbazepine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Extended-release tablet | ||||
| 150 mg | Oral | Ajanta Pharma USA Inc. | ANDA | View NDC → |
| 300 mg | Oral | Ajanta Pharma USA Inc. | ANDA | View NDC → |
| 600 mg | Oral | Ajanta Pharma USA Inc. | ANDA | View NDC → |
| 150 mg | Oral | Apotex Corp. | ANDA | View NDC → |
| 300 mg | Oral | Apotex Corp. | ANDA | View NDC → |
| 600 mg | Oral | Apotex Corp. | ANDA | View NDC → |
| 150 mg | Oral | Ingenus Pharmaceuticals, LLC | ANDA | View NDC → |
| 300 mg | Oral | Ingenus Pharmaceuticals, LLC | ANDA | View NDC → |
| 600 mg | Oral | Ingenus Pharmaceuticals, LLC | ANDA | View NDC → |
| 💊Oral suspension | ||||
| 300 mg/5 mL | Oral | Advagen Pharma Ltd × 3 listings | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Akorn | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Amneal Pharmaceuticals LLC × 3 listings | ANDA | View NDC → |
| 60 mg/mL | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 300 mg/5 mL | Oral | AvPAK × 2 listings | ANDA | View NDC → |
| 60 mg/mL | Oral | Biocon Pharma Inc. | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Bionpharma Inc. × 2 listings | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| 60 mg/mL | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Chartwell Governmental & Specialty RX, LLC. | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Epic Pharma, Llc × 2 listings | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Glasshouse Pharmaceuticals Limited Canada | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Kanchan Healthcare Inc | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Marlex Pharmaceuticals, Inc | ANDA | View NDC → |
| 60 mg/mL | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 60 mg/mL | Oral | Novartis Pharmaceuticals Corporation × 3 listings | NDA | View NDC → |
| 300 mg/5 mL | Oral | Precision Dose, Inc. × 2 listings | ANDA | View NDC → |
| 300 mg/5 mL | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 60 mg/mL | Oral | Sandoz Inc × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 60 mg/mL | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 300 mg/5 mL | Oral | West-Ward Pharmaceuticals Corp. | ANDA | View NDC → |
| 💊Tablet | ||||
| 300 mg | Oral | A-S Medication Solutions | ANDA | Find on DailyMed ↗ |
| 150 mg | Oral | Advagen Pharma Limited × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Advagen Pharma Limited × 2 listings | ANDA | View NDC → |
| 600 mg | Oral | Advagen Pharma Limited × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | Advagen Pharma Ltd. | ANDA | View NDC → |
| 300 mg | Oral | Advagen Pharma Ltd. | ANDA | View NDC → |
| 600 mg | Oral | Advagen Pharma Ltd. | ANDA | View NDC → |
| 150 mg | Oral | American Health Packaging × 6 listings | ANDA | View NDC → |
| 300 mg | Oral | American Health Packaging × 6 listings | ANDA | View NDC → |
| 600 mg | Oral | American Health Packaging × 6 listings | ANDA | View NDC → |
| 150 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 600 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Asclemed Usa Inc. | ANDA | View NDC → |
| 150 mg | Oral | AvPAK × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | AvPAK × 2 listings | ANDA | View NDC → |
| 600 mg | Oral | AvPAK × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | Breckenridge Pharmaceutical, Inc. × 4 listings | ANDA | View NDC → |
| 300 mg | Oral | Breckenridge Pharmaceutical, Inc. × 4 listings | ANDA | View NDC → |
| 600 mg | Oral | Breckenridge Pharmaceutical, Inc. × 4 listings | ANDA | View NDC → |
| 150 mg | Oral | Bryant Ranch Prepack × 4 listings | ANDA | View NDC → |
| 300 mg | Oral | Bryant Ranch Prepack × 10 listings | ANDA | View NDC → |
| 600 mg | Oral | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| 150 mg | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 600 mg | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | Cardinal Health | ANDA | View NDC → |
| 300 mg | Oral | Cardinal Health | ANDA | View NDC → |
| 150 mg | Oral | Cardinal Health 107, LLC × 7 listings | ANDA | View NDC → |
| 300 mg | Oral | Cardinal Health 107, LLC × 7 listings | ANDA | View NDC → |
| 150 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 300 mg | Oral | Coupler LLC × 3 listings | ANDA | View NDC → |
| 600 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 150 mg | Oral | DirectRx × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | Direct_rx | ANDA | View NDC → |
| 150 mg | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 600 mg | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 150 mg | — | Patheon Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 300 mg | — | Patheon Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 600 mg | — | Patheon Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 150 mg | Oral | Supernus Pharmaceuticals, Inc. × 3 listings | NDA | View NDC → |
| 300 mg | Oral | Supernus Pharmaceuticals, Inc. × 3 listings | NDA | View NDC → |
| 600 mg | Oral | Supernus Pharmaceuticals, Inc. × 3 listings | NDA | View NDC → |
| 150 mg | Oral | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 300 mg | Oral | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 600 mg | Oral | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 150 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 300 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 600 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 150 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 300 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 600 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Alivus Life Sciences Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Almon Healthcare Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.) | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Archimica S.p.A. × 4 listings | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | Archimica S.p.A. × 2 listings | BULK INGREDIENT | View NDC → |
| 50 kg/50 kg | — | Archimica S.p.A. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Aurore Pharmaceuticals Private Limited | BULK INGREDIENT | View NDC → |
| 20 kg/20 kg | — | Bajaj healthcare Ltd | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | CTX Lifesciences Pvt. Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Dasami Lab Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | F.i.s. Fabbrica Italiana Sintetici S.p.a. × 6 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Honour Lab Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hubei Gedian humanwell Pharmaceutical Co., Ltd | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hubei Gedian Humanwell Pharmaceutical Co.,Ltd | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Jubilant Biosys limited × 2 listings | BULK INGREDIENT | View NDC → |
| 30 kg/30 kg | — | Lianhe Chemical Technology Co.,Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | MSN Life Sciences Private Limited | BULK INGREDIENT | View NDC → |
| 35 kg/35 kg | — | Nuray Chemicals Private Limited | BULK INGREDIENT | View NDC → |
| 35 kg/35 kg | — | Sthree Chemicals Private Limited | BULK INGREDIENT | View NDC → |
Showing 200 of 320 products — FDA National Drug Code Directory. See every product, package size and price: browse all 320 Oxcarbazepine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Oxcarbazepine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Oxcarbazepine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Oxcarbazepine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 32624 3 dose forms · 7 strengths
-
Dose form (SCDF) Extended Release Oral Tablet RxCUI 1365652In current FDA listingsClinical drug / strength (SCD) 24 HR oxcarbazepine 150 MGRxCUI 136565324 HR oxcarbazepine 300 MGRxCUI 136584224 HR oxcarbazepine 600 MGRxCUI 1365844 -
Dose form (SCDF) Oral Suspension RxCUI 375197In current FDA listingsClinical drug / strength (SCD) 60 MG/MLRxCUI 283536 -
Dose form (SCDF) Oral Tablet RxCUI 373175In current FDA listings
Look up RxCUI 32624 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Oxcarbazepine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Oxcarbazepine belongs to the Anti-epileptic Agent class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 77 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Novartis Pharmaceuticals Corporation is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.